BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34043151)

  • 1. Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation.
    Yuan S; Bruzelius M; Larsson SC
    J Thromb Thrombolysis; 2022 Jan; 53(1):43-50. PubMed ID: 34043151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal relationship between moderate to vigorous physical activity and venous thromboembolism.
    Hu M; Wang X; Yang Y
    J Thromb Thrombolysis; 2023 Apr; 55(3):576-583. PubMed ID: 36595107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leisure sedentary behaviour increases the risk of venous thromboembolism: a Mendelian randomisation study.
    Chen L; You G; Yang Z; Shen R; Zhang R; Zhu D; Wang L; Lin S; Lv L; Huang K
    BMC Cardiovasc Disord; 2023 Jul; 23(1):362. PubMed ID: 37464328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Genetically Predicted Red Blood Cell Traits on Venous Thromboembolism: Multivariable Mendelian Randomization Study Using UK Biobank.
    Luo S; Au Yeung SL; Zuber V; Burgess S; Schooling CM
    J Am Heart Assoc; 2020 Jul; 9(14):e016771. PubMed ID: 32635790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism.
    Ji L; Shu P
    Arthritis Res Ther; 2023 Jul; 25(1):122. PubMed ID: 37468959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Cytokines and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
    Hu T; Su P; Yang F; Ying J; Chen Y; Cui H
    Thromb Haemost; 2024 May; 124(5):471-481. PubMed ID: 38109907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Hyperthyroidism on Venous Thromboembolism: A Mendelian Randomization Study.
    Han F; Zhang C; Xuan M; Xie Z; Zhang K; Li Y
    J Immunol Res; 2022; 2022():2339678. PubMed ID: 36277472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
    Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
    J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous Thromboembolism.
    Hu M; Gong Z; Yang Y
    J Atheroscler Thromb; 2023 Sep; 30(9):1265-1275. PubMed ID: 36529488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study.
    Ma XS; Sun J; Geng R; Zhao Y; Xu WZ; Liu YH; Jiang YN; Li YQ
    Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1087-1092. PubMed ID: 36958971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a mendelian randomization study.
    Qin Q; Pan Y; Wang L
    J Thromb Thrombolysis; 2024 Jan; 57(1):117-123. PubMed ID: 37615800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The causal relationship between COVID-19 and estimated glomerular filtration rate: a bidirectional Mendelian randomization study.
    Li Q; Lin M; Deng Y; Huang H
    BMC Nephrol; 2024 Jan; 25(1):21. PubMed ID: 38225574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.
    Lv X; Gao X; Liu J; Deng Y; Nie Q; Fan X; Ye Z; Liu P; Wen J
    Front Immunol; 2022; 13():1042751. PubMed ID: 36582224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tea intake and risk of kidney stones: A mendelian randomization study.
    Liu D; Wang J; Chen Y; Liu F; Deng Y; Wang M
    Nutrition; 2023 Mar; 107():111919. PubMed ID: 36542873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
    Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
    Nazarzadeh M; Bidel Z; Mohseni H; Canoy D; Pinho-Gomes AC; Hassaine A; Dehghan A; Tregouet DA; Smith NL; Rahimi K;
    Cardiovasc Res; 2023 May; 119(3):835-842. PubMed ID: 36031541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An insight into the causal relationship between sarcopenia-related traits and venous thromboembolism: A mendelian randomization study.
    Du X; Yao Z; Wang D; Dong X; Bai J; Gu Y; Yu Y; Zhang W; Qi Q; Gu S
    PLoS One; 2024; 19(5):e0303148. PubMed ID: 38753690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically predicted cortisol levels and risk of venous thromboembolism.
    Allara E; Lee WH; Burgess S; ; Larsson SC
    PLoS One; 2022; 17(8):e0272807. PubMed ID: 35984822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between genetically predicted TIMP-3 levels and risk of venous thromboembolism: A two sample Mendelian randomization study.
    Li Y; Wang X; Zhang X; Chen Q; Shi X; Zhang B; Xu J; Han B
    J Pharm Biomed Anal; 2024 Jun; 248():116290. PubMed ID: 38878456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary sclerosing cholangitis causally affects kidney function decline: A Mendelian randomization study.
    Cho JM; Koh JH; Kim SG; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK; Park S
    J Gastroenterol Hepatol; 2024 Jan; 39(1):185-192. PubMed ID: 37726875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.